Search

Your search keyword '"Verhoef, Senno"' showing total 380 results

Search Constraints

Start Over You searched for: Author "Verhoef, Senno" Remove constraint Author: "Verhoef, Senno"
380 results on '"Verhoef, Senno"'

Search Results

1. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

2. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

4. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

5. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

7. Prediction of breast cancer risk based on profiling with common genetic variants.

8. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

9. Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

10. Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

11. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

12. Genome-wide association analysis identifies three new breast cancer susceptibility loci

13. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

15. Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34

16. Data from Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

17. Supplementary Materials and Methods, Tables 1-5 from Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

18. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

19. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

20. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

21. Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients’ and health professionals’ attitudes, experiences, and evaluation of effects on treatment decision making

22. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

23. Withdrawal from Genetic Counselling for Cancer

24. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer

25. A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes?

28. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

30. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair

31. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

33. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

36. 'We don't know for sure': discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations

38. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

39. TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes

40. High rate of mosaicism in tuberous sclerosis complex

41. A DGGE System for Comprehensive Mutation Screening of BRCA1 and BRCA2:: Application in a Dutch Cancer Clinic Setting

43. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

44. Exploring the link between MORF4L1 and risk of breast cancer

45. Identification and characterization of the tuberous sclerosis gene on chromosome 16

50. ‘We don’t know for sure’: discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations

Catalog

Books, media, physical & digital resources